Observations on Screening-Based Research and Some Concerning Trends in the Literature

• Baell JB , HollowayGA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.J. Med. Chem.53(7), 2719–2740 (2010).
   PubMed Web of Science ®Google Scholar
• McLean LR , ZhangY, LiH. et al. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening. Bioorg. Med. Chem. Lett.23, 6717–6720 (2009).
   Google Scholar
• Ifa DR , RodriguesCR, de Alencastro RB, Fraga CAM, Barriero EJ. A possible molecular mechanism for the inhibition of cysteine proteases by salicylaldehyde N-acylhydrazones and related compounds. J. Mol. Struct.505, 11–17 (2000).
   Web of Science ®Google Scholar
• Kaumanns O , MayrH. Electrophilicity parameters of 5-benzylidene-2,2-dimethyl[1,3]dioaxane-4,6-diones (benzylidene Meldrum’s acids).J. Org. Chem.73(7), 2738–2745 (2008).
   PubMed Web of Science ®Google Scholar
• Regland B , LehmannW, AbediniI. et al. Treatment of Alzheimer’s disease with clioquinol. Dement. Geriatr. Cogn Disord.12(6), 408–414 (2001).
   PubMed Web of Science ®Google Scholar
• Ledesma GN , SierraMG, EscandarGM. Spectroscopic and theoretical study or aromatic α-hydroxy hydrazones and their copper (II) complexes in dioxane-water mixtures.Polyhedron17, 1517–1523 (1998).
   Web of Science ®Google Scholar
• Ainscough EW , BrodieAM, DennyWA, FinlayGJ, GotheSA, RanfordJD. Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes: quantitative structure–activity relationships.J. Inorg. Biochem.77, 125–133 (1999).
   PubMed Web of Science ®Google Scholar
• Forino M , JohnsonS, WongTYet al. Efficient synthetic inhibitors of anthrax lethal factor. Proc. Natl Acad. Sci USA 102, 9499–9504 (2005).
   PubMed Web of Science ®Google Scholar
• Powers JP , PiperDE, LiYet al. SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. J. Med. Chem. 49, 1034–1046 (2006).
   PubMed Web of Science ®Google Scholar
• Lee G , PiperDE, WangZet al. Novel inhibitors of hepatitis C virus RNA-dependent RNA polymerase. J. Mol. Biol. 357, 1051–1057 (2006).
   PubMed Web of Science ®Google Scholar
• Carter PH , ScherlePA, MuckelbauerJAet al. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α. Proc. Natl Acad. Sci. USA 98, 11879–11884 (2001).
   PubMed Web of Science ®Google Scholar
• Voss ME , CarterPH, TebbenAJet al. Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-α antagonists. Bioorg. Med. Chem. Lett. 13, 533–538 (2003).
   PubMed Web of Science ®Google Scholar
• Carlson EE , MayJF, KiesslingLL. Chemical probes of UDP-galactopyranose mutase.Chem. Biol.13, 825–837 (2006).
   PubMed Web of Science ®Google Scholar
• van Delft MF , WeiAH, MasonKDet al. The BH3 mimetic ABT-737-targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10, 389–399 (2006).
   PubMed Web of Science ®Google Scholar
• Degterev A , LugovskyA, CardoneMet al. Identification of small-molecule inhibitors of the interaction between the BH3 domain and Bcl-xL. Nature Cell Biol. 3, 173–182 (2001).
   PubMed Web of Science ®Google Scholar
• Ramesh C , NayakTK, BuraiRet al. Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. J. Med. Chem. 53(3), 1004–1014 (2010).
   PubMed Web of Science ®Google Scholar
• Wolf MC , FreibergAN, ZhangTet al. A broad-spectrum antiviral targeting entry of enveloped viruses. Proc. Natl Acad. Sci. USA 107(7), 3157–3162 (2010).
   PubMed Web of Science ®Google Scholar
• Rizvi SA , NeidtEM, CuiJet al. Identification and characterization of a small molecule inhibitor of formin-mediated actin assembly. Chem. Biol. 16(11), 1158–1168 (2009).
   PubMedGoogle Scholar
• Bowers EM , YanG, MukherjeeCet al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem. Biol. 17(5), 471–482 (2010).
   PubMedGoogle Scholar
• Kaiser J . Industry-style screening meets academic biology.Science321(5890), 764–766 (2008).
   PubMed Web of Science ®Google Scholar
• Smith AJT , ZhangX, LeachAG, HoukKN. Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.J .Med. Chem.52(2), 225–233 (2009).
   PubMed Web of Science ®Google Scholar
• Johnson DS , WeerapanE, CravattBF. Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.Future Med. Chem.2(6), 949–964 (2010).
   PubMed Web of Science ®Google Scholar
• Aghajan M , JonaiN, FlickKet al. Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase. Nature Biotechnol. 28(7), 738–744 (2010).
   PubMed Web of Science ®Google Scholar
• Rishton GM . Reactive compounds and in vitro false positives in HTS. Drug Discov. Today2, 382–384 (1997).
   Web of Science ®Google Scholar
• Hann M , HudsonB, LewellX, LifelyR, MillerL, RamsdenN. Strategic pooling of compounds for high-throughput screening.J. Chem. Inf. Comput. Sci.39, 897–902 (1999).
   PubMedGoogle Scholar
• Walters WP , MurckoMA. Prediction of ‘drug-likeness’. Adv.Drug. Deliv. Rev.54, 255–271 (2002).
   PubMed Web of Science ®Google Scholar
• Huth JR , MendozaR, OlejniczakETet al. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. J. Amer. Chem. Soc. 127, 217–224 (2005).
   PubMed Web of Science ®Google Scholar
• Thorne N , AuldDS, IngleseJ. Apparent activity in high-throughput screening: origins of compound-dependent assay interference.Curr. Opin. Chem. Biol.14, 315–324 (2010).
   PubMed Web of Science ®Google Scholar
• Lor LL , SchneckJ, McNultyDEet al. A simple assay for detection of small-molecule redox activity. J. Biomol. Screen. 12, 881–890 (2007).
   PubMed Web of Science ®Google Scholar
• Johnston PA , SoaresKM, ShindeSNet al. Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents. Ass. Drug Develop. Technol. 6, 505–518 (2008).
   PubMed Web of Science ®Google Scholar
• Brown GR , BamfordAM, BowyerJet al. Naphthyl ketones: a new class of janus kinase 3 inhibitors. Bioorg. Med. Chem. Lett. 10(6), 575–579 (2000).
   PubMed Web of Science ®Google Scholar
• Arnold LA , Estebanez-PerpinaE, TogashiMet al. Discovery of small molecule inhibitors of the interaction of the thyroid hormone-receptor with transcriptional coregulators. J. Biol. Chem. 280(52), 43048–43055 (2005).
   PubMed Web of Science ®Google Scholar
• Hwang JY , ArnoldLA, ZhuFet al. Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors. J. Med. Chem. 52, 3892–3901 (2009).
   PubMed Web of Science ®Google Scholar
• Gao M , NettlesRE, BelemaMet al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465, 96–100 (2010).
   PubMed Web of Science ®Google Scholar
• Frye SV . The art of the chemical probe.Nat. Chem. Biol.6, 159–161 (2010).
   PubMed Web of Science ®Google Scholar
• Homer RW , SwansonJ, JilekRJ, HurstT, ClarkRD. SYBYL Line notation (SLN): a single notation to represent chemical structures, queries, reactions and virtual libraries.J. Chem. Inf. Model.48(12), 2294–2307 (2008).
   PubMed Web of Science ®Google Scholar
• Gorsuch S , BavetsiasV, RowlandsMGet al. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs). Bioorg. Med. Chem. 17(2), 467–474 (2009).
   PubMed Web of Science ®Google Scholar
• Martin DC , JonesDC, FairlambAH, ClardyJ. High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity.Bioorg. Med. Chem. Lett.17(5), 1280–1283 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• Collaborative drug discovery blog. http://collaborativedrug.com/blog/blog/2010/03/08/guest-blog-dr-jonathan-baell
   Google Scholar
• Christopher A Lipinski Presesentation. http://collaborativedrug.com/blog/files/2009/10/Lipinski_CDD_usergroup100109-with-Kellan-alerts-slide.pdf
   Google Scholar